Selected Key Figures


Sales (€ million) +12.1%

EBITDA before special items (€ million) +18.2%

Net Income (€ million) +20.0%

Chairman’s Letter


“Being successful as a Life Science company requires a pronounced innovation culture that is the breeding ground for new ideas and facilitates their translation into successful products.”

Bayer Stock


Share Performance 2015

4.97

Earnings
per Share

Dividend per Share (€)

Performance Data


Sales (prior-year figures in brackets)

49% (46%)
HealthCare
Pharma 29% (29%)
Consumer Health 20% (17%)
22% (23%)
CropScience
26% (28%)
Covestro
2% (3%)
Reconciliation
46.324 € billion
(41.3 € billion)

R&D Expenses (€ million)

2,834
HealthCare
Pharma 2,333
Consumer Health 501
1,089
CropScience
262
Covestro
4,281

Employees by Region 2015 (prior-year figures in brackets)

16,000 (15,800)
North America
55,900 (54,600)
Europe
28,800 (30,200)
Asia
Pacific
16,100 (16,800)
Latin America
Africa
Middle East
116,800
(117,400)

Life Science Magazine

Share this page on